[Modified Chaihu Shugan Powder alleviates cholesterol gallstones in mice with liver depression syndrome by regulating gut microbiota and bile acid metabolism].
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
OBJECTIVES: (CHSGS) in mice with cholesterol gallstones (CS) and liver depression syndrome and its potential mechanism. METHODS: =51) with CS induced by high-lithogenic diet feeding. After verification of successful modeling in 3 mice, the remaining 48 mouse models were divided into CS group, CS-liver depression (CS-LD) group, CHSGS group, and ursodeoxycholic acid (UDCA) group, and the latter 3 groups were subjected to CS-LD modeling by chronic unpredictable mild stress (CUMS) and solitary raising and treated with saline, CHSGS or UDCA gavage for 3 weeks. The mice were assessed for general state, body weight, depressive behavior, ileal pathologies, biliary total cholesterol (TC) and total bile acid (TBA) levels, and ileal mRNA expressions of TGR5, GLP-1, and GLP-2 using q-PCR. 16S rDNA sequencing and metabolomics studies were used to analyze fecal microbiota and bile acids of the mice. RESULTS: . Bile acid profiling revealed significant upregulation of TDCA, DCA, and GDCA in CS group and increased CA and 3-ketodeoxycholic acid levels in CS-LD group. Correlation analysis suggested positive correlations between pro-lithogenic bile acids and the harmful gut bacteria. CONCLUSIONS: Modified CHSGS alleviates liver depression and cholesterol gallstones in mice likely by ameliorating gut microbiota dysbiosis and bile acid metabolism disorders.
Fields of Study & Subjects
Gut microbiota and health
Traditional Chinese Medicine Studies
Gallbladder and Bile Duct Disorders
Publication details
- Journal / source
- PubMed Central
- Volume
- 46
- Issue
- 3
- Pages
- 615–628
- Publication date
- 20 March 2026
- Language
- ZH